Over 1250 Cleansweep Auctions End Today - Bid Now
Over 750 Total Lots Up For Auction at Five Locations - Over 800 Texas Auctions End Tomorrow 09/30 - Bid Now, NC 10/05, FL 10/06, CA 10/07, NY 10/11

Answering the worldwide need for chronic liver disease assessment and diagnosis

September 20, 2019

Jon Gingrich, CEO, Echosens North America: With more than 20 years of global medical device and health care sales, marketing and general management experience at AxoGen, Inc., Hologic, Inc., Boston Scientific Corporation and Unilever, N.V, Gingrich now leads the development and execution of the Echosens U.S. strategy for expanding the utilization of FibroScan technology in the assessment of chronic liver disease. As a member of the broader global executive leadership team, he works to implement the Company’s transformation plan and shape the future of Echosens.

Back to HCB News

You Must Be Logged In To Post A Comment